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ABSTRACT 
 
Suppressor  of  Cytokine  Signaling  (SOCS)  proteins  are  the  negative  regulators  of 
cytokine  signals  as  a  natural  precaution  to  prevent  excessive  responses  that  could 
cause damage to body tissues. However, their over expression is suggested to inhibit 
the anti proliferative and antiviral activities of Interferon (IFN). Several viruses including 
HIV 1 have been reported to exploit the SOCS proteins for minimizing the activity of 
Interferon (IFN). Hence, the attempts to regulate the SOCS expression may be a novel 
roadblock  into  viral  proliferation  and  pathogenesis.  Present  review  is  an  effort  to 
summarize the SOCS contribution in viral contagion and future therapeutic prospects 
against  HIV 1.  Running  Head   Aberrant  SOCS  expression:  a  target  for  anti HIV 
research 
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INTRODUCTION 
 
Current therapies that directly target to virus 
are often ineffective due to emergence of drug 
resistance  and  viral  variants.  Therefore, 
targeting  to  host  mechanisms  that  are 
essential for the propagation of virus but have 
a  minimal  cellular  effect  is  an  emerging 
concept  to  combat  drug  resistance. 
Suppressors  of  Cytokine  Signaling  (SOCS) 
protein  family  is  one  amongst  the  recently 
identified  group  of  host  proteins  that  can  be 
exploited  by  virus  for  their  own  benefits. 
Members of this family are induced at infection 
by  a  number  of  different  viruses,  including 
HIV 1,  Hepatitis C Virus (HCV), Hepatitis B 
Virus  (HBV),  Herpes  Simplex  Virus  type  1 
(HSV 1) etc. to subsequently contribute in viral 
replication  and  pathogenesis  (Akhtar  and 
Benveniste,  2011).  Normally,  SOCS  proteins 
negatively regulate the cytokine signals as a 
natural  precaution  to  prevent  ‘out of control’ 
responses that could cause collateral damage 
to body tissues. But over expression of SOCS 
proteins  are  suggested  to  suppress  even 
required  immune  response  added  with 
inhibition of the anti proliferative and antiviral 
activities  of  Interferon  (IFN).  Interferon  is  a 
pleiotropic  cytokine  produced  primarily  by  T 
lymphocytes  and  Natural  Killer  (NK)  cells  in 
response  to  viral  infection  (Schroder  et  al., 
2004).    It  is  an  important  mediator  with 
multiple  biological  activities  such  as 
macrophage  activation  and,  antimicrobial, 
anti proliferative  and  immunomodulatory 
effects (Samuel, 2001). At cellular level, IFN 
induce the activation of Janus kinase 1 (Jak1) 
and Jak2 and consequent phosphorylation of 
STAT1  which  finally  leads  to  initiation  of 
transcription  after  dimerization  (Song  and 
Shuai,  1998;  Stoiber  et  al.,  1999;  Platanias, 
2005). But in AIDS patients, the IFN signaling 
cascade is inhibited proximally at the level of 
STAT1  phosphorylation  by  viral  Tat  protein 
and therefore opens a window of leeway for 
opportunistic  microbial  infection  in  HIV 
infected hosts (Fig 1) (Cheng et al., 2009).  
 
SOCS Protein family 
SOCS  protein  family  including  SOCS 1  to 
SOCS 7  and  cytokine inducible  SH2  protein 
(CIS) represents the eight different members 
(Fig 2).  They  consist  of  the  inhibitors  of 
activated STATs (PIAS) and Scr homology 2 
(SH2)  containing  protein  tyrosine 
phosphatases (SHPs) which contribute to the 
negative  regulation  of  cytokine  signaling 
(Danielle and Douglas, 2000). However, so far 
only first four proteins; CIS, SOCS 1, SOCS 2 
and  SOCS 3  are  reported  to  be  induced  by 
cytokines. No clear evidences for the cytokine 
induced  expression  of  SOCS 4,  SOCS 5, 
SOCS 6 and SOCS 7 mRNAs are found. The 
first  four  proteins  are  induced  by  cytokine 
stimulation  and  inhibit  to  the  same  cascade 
initiating  their  production  by  a  classical 
negative  feedback  mechanism  (Larsen  and 
Röpke, 2002). 
 
Suppression of cell signaling 
A  cytokine  after  binding  to  their  respective 
receptors  cause  phosphorylation  of  the 
cytoplasmic receptor domain and rise in JAK 
STAT  phosphorylation  (Yoshimura  et  al., 
1995;  Endo  et  al.,  1997;  Starr  et  al.,  1997). 
But subsequent SOCS induction seems to be 
able  to  stop  further  signal  transduction  by 
inhibiting various steps in this cascade (Fig 1). 
The  over  expression  of  SOCS 1,  SOCS 2, 
SOCS 3 and CIS in cell lines have resulted in 
reduced  phosphorylation  of  JAKs  or  STATs 
(Naka  et  al.,  1997;  Starr  et  al.,  1997;  Song 
and  Shuai,  1998),  diminished  STAT 
dimerisation  (Starr  et  al.,  1997),  jumbled 
import  of  STAT  to  the  nucleus  (Song  and 
Shuai, 1998) and finally reduced transcription 
of target genes (Endo et al., 1997) caused by 
a wide range of cytokines (Yoshimura et al., 
1995;  Starr  et  al.,  1997).  Suppressor  of 
Cytokine Signalling 1 (SOCS 1) is one of the 
proteins responsible for negative regulation of 
JAK STAT pathway.This involves the complex 
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particular  structural  domains  (KIR,  ESS  and 
SH2) present on SOCS 1. JAKs and STATs 
are  the  receptor  associated  tyrosine  kinases 
and  cytoplasmic  transcription  factors  which 
communicate the cytokine effect within the cell 
(Imada  and  Leonard,  2000).  This  complex 
cascade  is  crucial  for  the  cell  development, 
hematopoiesis and host defence and requires 
precise  control  and  regulation.  It  has  been 
reported  that  SOCS  can  modulate  the  host 
response  to  IFN  and  prevent  activation  of 
STAT 1. Moreover, SOCS proteins have also 
been reported to inhibit the cytokine induced 
signaling cascade for ubiquitination of proteins 
and proteosomal degradation. Hence, SOCS 
proteins  may  lead  the  host  to  infection, 
contribute to disease manifestations such as 
immune  dysfunction  and  cancer,  and  even 
modify  the  efficacy  of  therapeutic 
interventions.  
 
Behavior  of  SOCS  proteins  in  viral 
infection 
It  was  recognized  that  viruses  could  hijack 
host  SOCS  proteins  to  manipulate  antiviral 
IFN signaling for their advantage. Hepatitis C 
Virus  (HCV),  a  small,  positive sense,  single 
stranded  RNA  (ssRNA)  virus  that  infects 
hepatocytes  of  the  liver  to  cause  liver 
inflammation  (hepatitis),  was  the  first  virus 
reported  to  independently  induce  SOCS 
expression  (Bode,  2003).  In  continuation  of 
that, effect of Mycobacterium avium has also 
been investigated on SOCS members for its 
inhibiting properties on the activation of IFN 
gamma  induced  STAT 1.  M.  avium  is  an 
opportunistic  pathogen  commonly  attacks 
HIV 1  colonized  individuals.  It  interacts  with 
TLR2 and/or CD14 co receptors and invades 
macrophages.  This  is  observed  that  the  M. 
avium  in  collaboration  with  macrophage 
receptors  resulting  in  the  elevated  gene 
expressions  of  the  SOCS  which  further 
causes  diminished  IFN  responsiveness  with 
suppressed phosphorylation of STAT 1 in M. 
avium  infected  cells  as  compared  to 
uninfected cells (Vázquez et al., 2006). 
However,  numerous  viruses  are  used 
to “hijack” the SOCS function promoting viral 
survival,  as  SOCS  proteins  inhibit  protective 
antiviral  signaling  pathways,  thus  allowing 
facilitation  of  viral  proteins,  intracellular  viral 
trafficking and viral progeny assembly. Hence 
the SOCS proteins not only allow progression 
of viral life cycle but also powerfully shape the 
presentation  of  viral  diseases  (Akhtar  and 
Benveniste, 2011). It inhibits the signaling by a 
wide range of cytokines including interleukin 2 
(IL 2) (Sporri et al., 2001), interleukin 4 (IL 4), 
interleukin 6 (IL 6), leukaemia inhibitory factor 
(LIF) (Starr et al., 1997), interferon γ (IFN γ) 
(Sakamoto et al., 1998), growth hormone (GH) 
(Ram and Waxman, 1999) and prolactin (PRL) 
(Tomic et al., 1999). 
Moreover,  influenza  A  virus  has  also  been 
testified  for  its  suppressive/inhibitory  effects 
on interferon (IFN) beta gene by a mechanism 
comprising  generation  of  the  suppressor  of 
cytokine  signaling 3  (SOCS 3)  protein. 
Because  the  influenza  A  virus  infected  cells 
were  reported  to  have  strongly  condensed 
phosphorylation of the signal transducer and 
activator  of  transcription  protein  1  (STAT1) 
(Pothlichet et al., 2008). This impaired STAT1 
activation  is  believed  to  appear  due  to 
accumulation  of  viral  5'  triphosphate  RNA  in 
the cell.  
 
SOCS proteins in HIV-1 infection 
The interplay between viruses and host cells 
determine the outcomes of viral pathogenesis, 
ranging from elimination of viruses to latent or 
lethal infections. HIV 1 is not an exception. In 
fact,  individuals  with  defective  cell  surface 
receptor (CCR5) express resistance to HIV 1 
infection  (Liu  et  al.,  1996;  Samson  et  al., 
1996)  while  soluble  mediators  including 
cytokines  and  viral  products  such  as  Tat, 
produced by infected cells augments the HIV 
1 infection either by direct effects or through 
deregulation  of  cytokine  expression  viz. 
Interferon  (IFN)  and  Tumor  Necrosis  Factor 
(TNF) (Sui et al., 2009; Wheeler et al., 2007). 
Several similar interactions have been  Int J Pharm Bio Sci 2012 Oct; 3(4): (B) 1137 - 1144 
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reported  to  encompass  nearly  every  step  of 
HIV 1  life  cycle  starting  from  viral  entry 
(Moore,  1997)  to  viral  budding  and  release 
(Garrus et al., 2001). 
SOCS proteins are induced by viruses 
including  HIV 1  to  promote  the  successful 
completion of their own life cycle. Its aberrant 
expression  can  powerfully  shape  the  overall 
presentation of viral disease by contributing to 
the peripheral manifestations of viral infection. 
For  example,  the  direct  result  of  HIV 1 
replication is CD4
+ T cell death (Dwivedi et al., 
2011) but the most often manifestation of HIV 
1  disease  may  be  opportunistic  infection  by 
the  pathogens  such  as  mycobacteria, 
protozoa,  and  fungi.  However,  these 
pathogens  are  cleared  in  the 
immunocompetent  host  primarily  by  T  cell 
mediated  IFN γ  signaling.  But  decreased  T 
cell  numbers  in  the  HIV 1  infected  host 
certainly  hinder  proper  clearance  of  them. 
Even  exogenous  supply  of  IFN γ  has  not 
shown  any  significant  effect  (Biggs  et  al., 
1995),  suggesting  that  nonproductive 
signaling is also at fault. It seems likely that 
HIV 1  induced  SOCS1  and  SOCS3  proteins 
provide a safe haven for M. avium and other 
opportunistic pathogens by inhibiting the IFN γ 
signaling.  
The cytokine expression in HIV positive 
individual  is  characterized  as  the  decreased 
production  of  pro inflammatory  cytokines  i.e. 
IL 12 and IFN γ and increased expression of 
the anti inflammatory cytokine IL 10. The IFN 
γ and IL 12 signaling network is fundamental 
to  the  Th1  differentiation  program  and  in 
controlling  immunity  against  HIV 1  infection 
(Murphy et al., 2000). Therefore, the absence 
of IFN γ and IL 12 and better presence of IL 
10 sponsor the impaired innate and T helper 
type 1 (Th1) responses in AIDS patients (Ma 
and Montaner, 2000). Moreover, in relation to 
SOCS support to HIV 1, Wahl and colleagues 
observed  that  tonsil  mucosal  associated 
lymphoid tissues are much more susceptible 
to  HIV 1  infection  than  peripheral  blood 
mononuclear cells (PBMCs), due to the  
increased  levels  of  SOCS1  and  SOCS3 
present in these tissues (Moutsopoulos et al., 
2006).  Increased  SOCS  expression  in  tonsil 
tissues, both constitutively and in response to 
HIV 1  infection,  correlated    to  decrease 
STAT1 activation in response to IFN α and a 
decreased  TH1  response  in  the  presence  of 
IFN γ.  These  studies  suggest  that  SOCS 
expression  may  contribute  to  determining 
susceptibility  to  HIV 1  infection  by  inhibiting 
both  the  innate  and  adaptive  immune 
responses to infection.  
However, in early stage of HIV infection 
the  sustained  immune  activation  involves  T 
cells  stimulation  and  increased  levels  of 
phosphorylated  STAT  proteins  along  with 
partial inability of SOCS 1 and 3, inhibiting the 
JAK/STAT  pathway.  But,  in  later  stage,  the 
severe  infection  prevents  the  JAK/STAT 
activation,  responsible  for  cytokine  signaling 
mediated  cell  proliferation  and  differentiation 
of CD4
+ cells. Thus, HIV infection interfere the 
SOCS 1/3  expression  driving  immune 
activation.  Also,  at  later  stage  the  sustained 
immune  activation  disrupts  lymphoid  system 
and  favors  HIV 1  replication  (Miller and 
Schlaepfer,  2011).  Interestingly,  the  in vivo 
and  in vitro  experiments  have  also  validated 
that  SOCS 3  allows  HIV 1  to  evade  innate 
immunity. The SOCS 3 expression attenuates 
the  response  of  macrophages  to  IFN β  and 
thus  preventing  the  HIV 1  replication  from 
inhibitory  effect  of  IFN β  (Yoshimura  et  al., 
1995). Thus, it has been suggested a relation 
between  high  levels  of  SOCS 1/SOCS 3 
expression and defects in innate immunity and 
adaptive Th1 responses, that is redirected in 
the AIDS patients with the loss of Th1 immune 
competence (Yadav et al., 2009). Therefore, it 
suggests that increased understanding of HIV 
1 interaction with host protein could improve 
the  therapeutic  and  prevention  strategies  to 
combat HIV/AIDS. However, efforts have been 
begun to target specific host mechanisms that 
are essential for HIV 1 replication but not for 
host cell itself.  
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Conclusions & Future Prospective  
Above  discussion  has  demonstrated  the 
aberrant SOCS expression as a sponsor into 
shaping  and  overall  presentation  of  viral 
disease.  However,  in  recent  research  a  cell 
signalling  hormone  called  interleukin 7  (IL 7) 
which  reinvigorates  the  immune  response  to 
chronic  viral  infection  without  too  much 
collateral  tissue  damage,  has  been 
interestingly reported to cause suppression of 
SOCS gene expression at molecular level. In 
an  overwhelming  infection,  SOCS 3 
expression  causes  the  immune  system  to 
slam  on  brakes  too  early  and  allow  the 
infection to persist longer. But switching off the 
SOCS 3  gene  by  IL 7  has  boosted  the 
immune system to completely overcome and 
eliminate the infection. Since, SOCS proteins 
have  a  regulatory  interference  in  the 
polarization  of  CD4
+  T  cells  into  Th1,  Th2, 
Th17 and T regulatory cell lineages, therefore, 
turning off the SOCS 3 expression can allow 
the  immune  system  to  boost  the  number  of 
virus specific  T  cells  and  have  an  immune 
response good enough to eliminate the virus 
without  any  autoimmune  response.  This 
remarkable finding has provided an excellent 
platform  for  new  paradigm  to  develop  the 
advanced  therapies  that  could  boost  host 
immune response to fight disease, instead of 
targeting  the  disease  only.  It  could  help  to 
develop  new  drugs  that  target  SOCS 3  and 
turn  it  off  for  very  short,  defined  periods  of 
time to reinvigorate the T cells, allowing them 
to  regroup  to  fight  against  infection.  Hence 
SOCS expression can be a novel target to be 
regulated in viral diseases including AIDS in 
order  to  counteract  immune  activation. 
 
Figure 1 
SOCS-1 & SOCS-3 mediated suppression of cytokine signaling and inhibitory  
effect of viral Tat protein on STAT dimerization to stop gene expression. 
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Following  to  stimulation  of  the  cell  surface  receptor  subunits  IFN α/β  receptor  1  (IFNAR1)  and 
IFNAR2 by Interferon (IFN), receptor associated JAKs (JAK1 and TYK2) recruit and phosphorylate 
cytoplasmic  STAT1  and  STAT2.  The  STAT1 STAT2  heterodimer  associates  with  IFN regulatory 
factor 9 (IRF9) to form IFN stimulated gene factor 3 (ISGF3), which enters the nucleus and binds IFN 
stimulated regulatory elements (ISRE) in the promoters of hundreds of antiviral IFN stimulated genes 
(ISGs) to induce their expression. ISGs have been shown to inhibit every stage of viral replication, 
from viral entry and uncoating to assembly and release, providing the host with formidable protection 
against viral infection. 
 
Figure 2 
The alternative names and domain structures of the SOCS family members.  
The Kinase Inhibitory Region (KIR) of SOCS-1 and SOCS-3 is marked green. 
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